Dr. Choi was most recently at CRISPR Therapeutics as the Vice President of Process Development (PD) where the Process Design, MSAT and Facilities, Utilities and Systems Engineering groups reported into him. Immediately prior to CrisprTx, Dr. Choi served as the Global Head of PD Business Operations and PD Site Head for RDMC-E at Kite Pharma, a Gilead Company, where the Process Design (Cell and Gene Transfer), Analytical Development, MSAT, Lab Operations, Project Management and Knowledge Management groups reported into him. During his career, Dr. Choi has led the design, construction, Commissioning, Qualification, Validation, startup and operation of numerous GMP viral, cell and gene therapy manufacturing facilities. He has also been involved in numerous early and late-stage INDs as well as commercial BLAs and MAAs. Dr. Choi received his BS in Biology from the University of California at Irvine (UCI), his PhD in Molecular Microbiology and Immunology from the University of Southern California (USC) Keck School of Medicine, and his MBA from the Massachusetts Institute of Technology (MIT) Sloan School of Management.